Position in IMVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$286,329,959
-$6,685,643 QoQ
Shares Held
11,526,971
0.0% QoQ
Ownership
5.61%
of shares outstanding
% of Portfolio
5.91%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Deep Track Capital, LP holds $4,185,471,777 across 55 Biotechnology names. IMVT ranks #1 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
This page
|
11,526,971 | $286,329,959 | |
| 2 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,600,000 | $252,540,000 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,873,000 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
4,279,848 | $206,288,673 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
1,100,000 | $185,922,000 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,532,374 | $182,337,406 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $166,742,808 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
4,106,067 | $165,187,075 |
All Filings in IMVT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $286,329,959 | 11,526,971 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $293,015,602 | 11,526,971 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $156,828,981 | 9,728,845 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $152,000,000 | 9,500,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $162,355,000 | 9,500,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-19 | $179,360,000 | 9,500,000 | Shares | Sole | 2025-03-26 | |
| 2024-12-31 | $148,620,000 | 6,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $123,946,198 | 4,347,464 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $76,130,630 | 2,883,736 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,940,203 | 493,352 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $42,130,000 | 1,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $107,413,492 | 2,797,955 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $102,842,630 | 5,421,330 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $115,281,440 | 7,432,717 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $172,352,500 | 9,710,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $55,020,172 | 9,860,246 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,874,500 | 9,455,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $39,807,617 | 7,224,613 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $40,683,000 | 4,775,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||